Figure 9.
Quantification of Pax7-positive muscle satellite cells from (A) short-term treatment with either 1 µg or 5 µg FGF2 and (B) long-term treatment with sustained release FGF2 pellets after 1 month, 2 months, and 3 months. * Statistical difference from naïve control superior rectus muscle. # Statistical difference from pellet-treated superior rectus muscle.